RenovoRx Inc. said a clinical data abstract from Moffitt Cancer Center on metabolic response observations after chemotherapeutic delivery via its TAMP (Trans-Arterial Micro-Perfusion) therapy platform in locally advanced pancreatic cancer was accepted for presentation at the 2026 Society of Interventional Radiology Annual Scientific Meeting, to be held April 11-15, 2026, in Toronto, Ontario, with the presentation scheduled for April 13, 2026. Event-related materials: https://d1io3yog0oux5.cloudfront.net/_9d8563855964dc3f9fbefdae77b76b08/renovorx/news/2026-02-26_RenovoRx_Announces_Acceptance_of_Clinical_Data_149.pdf
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.